Summary

Global Patient Registry Software Market was valued at USD 2.11 Billion in 2024 and is expected to reach USD 3.66 Billion in the forecast period with a CAGR of 9.57% through 2030. Patient Registry Software is a specialized healthcare technology solution designed to collect, manage, and analyze comprehensive and structured data about patients with specific medical conditions, diseases, or characteristics. It serves as a centralized database for healthcare organizations, research institutions, and public health agencies to maintain detailed records of patients' medical histories, treatment outcomes, and other relevant information. Patient registries are often disease-specific, meaning they are tailored to gather data on patients with medical conditions. These conditions can range from common chronic diseases like diabetes or cardiovascular disorders to rare diseases or specific patient characteristics (e.g., pregnancy registries). To ensure consistency and interoperability, patient registry software often adheres to standardized data formats, coding systems (e.g., ICD-10, SNOMED CT), and medical terminology. Standardization is critical for data exchange and analysis. The software includes validation rules and checks to ensure that data entered the registry is accurate and adheres to predefined standards. Validation helps maintain data quality and reliability.
Key Market Drivers
Growing Epidemiological Studies
Epidemiological studies aim to understand the distribution and determinants of diseases within populations. Patient registry software is instrumental in these studies, offering structured and efficient data collection, storage, and management from diverse sources such as healthcare facilities, research institutions, and public health agencies. This systematic data collection is vital for large-scale epidemiological research.
Continuous monitoring of diseases is essential in epidemiology. Patient registry software facilitates real-time data capture and surveillance, enabling the identification of disease trends, outbreaks, and patterns. For instance, the OpenSAFELY platform in the UK has been pivotal in analyzing risk factors associated with COVID-19, utilizing data from approximately 58 million patients. Such platforms underscore the significance of patient registries in real-time health data analysis.
Key Market Challenges
Data Quality and Accuracy
Ensuring the reliability and precision of data within patient registries is crucial for their effectiveness in supporting healthcare research, clinical care, and public health initiatives. Human errors during data entry, such as typos or incorrect information, can lead to inaccuracies in patient records. Even minor mistakes can have significant implications for patient care and research. Missing or incomplete data fields within patient records can hinder the ability to derive meaningful insights from the registry. Incomplete data may result from oversight during data entry or limitations in data collection processes. Duplicate records for the same patient can distort statistics and analysis. Patient registry software should have mechanisms to detect and prevent duplicate entries. Inconsistencies in data format, terminology, or coding can make it challenging to perform accurate analyses and comparisons. Standardizing data entry and terminology is crucial for consistency. Ensuring that data entered the registry is valid and follows predefined rules and standards is essential. Without proper validation, inaccurate data may be included. Maintaining data security and privacy while ensuring data quality is a delicate balance. Stringent security measures may restrict data accessibility, potentially affecting data accuracy. The absence of clear data governance policies and procedures can lead to data quality issues. Establishing data governance frameworks helps maintain data accuracy and consistency.
Key Market Trends
Increased Adoption of Cloud-Based Solutions
Cloud-based patient registry software can easily scale up or down based on the needs of healthcare organizations. This flexibility is crucial as patient data volumes can vary significantly. Cloud solutions often eliminate the need for extensive on-premises hardware and infrastructure, reducing capital expenditures. Healthcare organizations can pay for cloud services on a subscription or pay-as-you-go basis, aligning costs with actual usage. Cloud-based patient registry software allows authorized users to access patient data and registry functions from virtually anywhere with an internet connection. This is particularly valuable for remote healthcare settings and telehealth initiatives. Reputable cloud providers invest heavily in security measures, often exceeding what individual healthcare organizations can implement. These providers offer robust data encryption, access controls, and disaster recovery options to protect patient data. Cloud-based solutions typically offer automated data backup and recovery capabilities, reducing the risk of data loss due to hardware failures or disasters. Cloud-based patient registry software can facilitate data sharing and interoperability by providing standardized interfaces and APIs. This enables integration with other healthcare systems, including EHRs and laboratory systems. Cloud vendors provide ongoing support, updates, and maintenance for the software, reducing the burden on healthcare IT staff.
Key Market Players
• Dacima Software Inc.
• FIGmd Inc.
• Global Vision Technologies Inc.
• Image Trend Inc.
• IQVIA
• Ordinal Data, Inc.
• McKensson Corporation
• Syneos Health
• Velos Inc.
• Cerner Corporation
Report Scope:
In this report, the Global Patient Registry Software Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Patient Registry Software Market, By Type of Registry:
o Disease Registries
o Health Service Registries
o Product Registries
• Patient Registry Software Market, By Type of Software:
o Stand-alone Software
o Integrated Software
• Patient Registry Software Market, By End User:
o Hospitals
o Government Organizations and Third-Party Administrators (TPAs)
o Pharmaceutical, Biotechnology, and Medical Device Companies
o Other
• Patient Registry Software Market, By region:
o North America
§ United States
§ Canada
§ Mexico
o Asia-Pacific
§ China
§ India
§ South Korea
§ Australia
§ Japan
o Europe
§ Germany
§ France
§ United Kingdom
§ Spain
§ Italy
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Patient Registry Software Market.
Available Customizations:
Global Patient Registry Software Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Patient Registry Software Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type of Registry (Disease Registries, Health Service Registries, Product Registries)
5.2.2. By Type of Software (Stand-alone Software, Integrated Software)
5.2.3. By End User (Hospitals, Government Organizations and Third-Party Administrators (TPAs), Pharmaceutical, Biotechnology, and Medical Device Companies, Other)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. Asia Pacific Patient Registry Software Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type of Registry
6.2.2. By Type of Software
6.2.3. By End User
6.2.4. By Country
6.3. Asia Pacific: Country Analysis
6.3.1. China Patient Registry Software Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type of Registry
6.3.1.2.2. By Type of Software
6.3.1.2.3. By End User
6.3.2. India Patient Registry Software Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type of Registry
6.3.2.2.2. By Type of Software
6.3.2.2.3. By End User
6.3.3. Australia Patient Registry Software Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type of Registry
6.3.3.2.2. By Type of Software
6.3.3.2.3. By End User
6.3.4. Japan Patient Registry Software Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Type of Registry
6.3.4.2.2. By Type of Software
6.3.4.2.3. By End User
6.3.5. South Korea Patient Registry Software Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Type of Registry
6.3.5.2.2. By Type of Software
6.3.5.2.3. By End User
7. Europe Patient Registry Software Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type of Registry
7.2.2. By Type of Software
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Patient Registry Software Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type of Registry
7.3.1.2.2. By Type of Software
7.3.1.2.3. By End User
7.3.2. Germany Patient Registry Software Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type of Registry
7.3.2.2.2. By Type of Software
7.3.2.2.3. By End User
7.3.3. Spain Patient Registry Software Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type of Registry
7.3.3.2.2. By Type of Software
7.3.3.2.3. By End User
7.3.4. Italy Patient Registry Software Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type of Registry
7.3.4.2.2. By Type of Software
7.3.4.2.3. By End User
7.3.5. United Kingdom Patient Registry Software Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type of Registry
7.3.5.2.2. By Type of Software
7.3.5.2.3. By End User
8. North America Patient Registry Software Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type of Registry
8.2.2. By Type of Software
8.2.3. By End User
8.2.4. By Country
8.3. North America: Country Analysis
8.3.1. United States Patient Registry Software Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type of Registry
8.3.1.2.2. By Type of Software
8.3.1.2.3. By End User
8.3.2. Mexico Patient Registry Software Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type of Registry
8.3.2.2.2. By Type of Software
8.3.2.2.3. By End User
8.3.3. Canada Patient Registry Software Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type of Registry
8.3.3.2.2. By Type of Software
8.3.3.2.3. By End User
9. South America Patient Registry Software Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type of Registry
9.2.2. By Type of Software
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Patient Registry Software Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type of Registry
9.3.1.2.2. By Type of Software
9.3.1.2.3. By End User
9.3.2. Argentina Patient Registry Software Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type of Registry
9.3.2.2.2. By Type of Software
9.3.2.2.3. By End User
9.3.3. Colombia Patient Registry Software Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type of Registry
9.3.3.2.2. By Type of Software
9.3.3.2.3. By End User
10. Middle East and Africa Patient Registry Software Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type of Registry
10.2.2. By Type of Software
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Patient Registry Software Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type of Registry
10.3.1.2.2. By Type of Software
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Patient Registry Software Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type of Registry
10.3.2.2.2. By Type of Software
10.3.2.2.3. By End User
10.3.3. UAE Patient Registry Software Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type of Registry
10.3.3.2.2. By Type of Software
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Patient Registry Software Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. PESTLE Analysis
16. Competitive Landscape
16.1. Dacima Software Inc.
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (In case of listed companies)
16.1.5. Recent Developments
16.1.6. SWOT Analysis
16.2. FIGmd Inc.
16.3. Global Vision Technologies Inc.
16.4. Image Trend Inc.
16.5. IQVIA
16.6. Ordinal Data, Inc.
16.7. McKensson Corporation
16.8. McKensson Corporation
16.9. Velos Inc.
16.10.Cerner Corporation
17. Strategic Recommendations
18. About Us & Disclaimer